These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Drug-induced agranulocytosis in rheumatology. A retrospective study of 12 cases]. Serraj K; Federici L; Maloisel F; Sibilia J; Andrès E Ann Biol Clin (Paris); 2007; 65(4):431-6. PubMed ID: 17627927 [TBL] [Abstract][Full Text] [Related]
27. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis]. Janković B; Pasić S; Marković M; Veljković D; Milicić M Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985 [TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
29. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
31. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073 [TBL] [Abstract][Full Text] [Related]
33. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF). Góra-Tybor J; Krykowski E; Robak T Arch Immunol Ther Exp (Warsz); 1996; 44(4):255-8. PubMed ID: 9017166 [TBL] [Abstract][Full Text] [Related]
34. [The effectiveness of granulocyte transfusions in the treatment of severe injections in granulocytopenic patients. A controlled trial (author's transl)]. Grañena A; Aranalde JM; Feliu E; Muncunill J; Montserrat E; Hernandez Nieto L; Rozman C Sangre (Barc); 1978; 23(3):291-7. PubMed ID: 675453 [No Abstract] [Full Text] [Related]
35. Infectious episodes in severely granulocytopenic patients. van der Meer JW; Alleman M; Boekhout M Infection; 1979; 7(4):171-5. PubMed ID: 511334 [TBL] [Abstract][Full Text] [Related]
36. [Granulocyte transfusion. Its efficacy as a complementary treatment of infections in the granulocytopenic patient (author's transl)]. Vivancos Pujol MP; Alemany A; Clavo M; Rubio Baget A; Sans Botargues R; Ferran C Sangre (Barc); 1979; 24(5B):896-903. PubMed ID: 524234 [No Abstract] [Full Text] [Related]
37. Granulocyte transfusion therapy: survival directly correlated with bone marrow recovery and the pathogenicity of the infectious organisms. Congdon JE; Flannery EP; Justice GR; Corder MP; Dabe I; Koker RH; Stone WH Mil Med; 1981 Jun; 146(6):393-6. PubMed ID: 6787464 [No Abstract] [Full Text] [Related]
38. Filtration leukopheresis granulocyte support for infected neutropenic patients. McLennan R; Bishop JF; Whiteside MG Med J Aust; 1977 Apr; 1(14):477-8. PubMed ID: 865368 [TBL] [Abstract][Full Text] [Related]
39. Granulocytopenia and cancer therapy. Past problems, current solutions, future challenges. Pizzo PA Cancer; 1984 Dec; 54(11 Suppl):2649-61. PubMed ID: 6437658 [TBL] [Abstract][Full Text] [Related]
40. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis. Andrès E; Federici L; Weitten T; Vogel T; Alt M Expert Opin Drug Saf; 2008 Jul; 7(4):481-9. PubMed ID: 18613811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]